Company: PFSA
Filing Date: 2025-05-15
Form Type: 424B3
Source: 0001213900-25-044417
Chunk: 27

Company: Profusa, Inc.
Filing Date: 2025-05-15
Form: 424B3
Chunk 27
---
 gross proceeds of $189,750,000. Simultaneously with the closing of the IPO, we consummated the sale of 7,347,500 private placement warrants to the Sponsor at a price of $1.00 per warrant, generating gross proceeds of $7,347,500. Subsequently, the units were separated on January21, 2022, resulting in NorthView’s shares of common stock, its warrants and its rights trading separately. •The NorthView Common Stock was originally sold in the IPO as a component of the NorthView units for $10.00 per unit. The NorthView units consisted of one share of NorthView Common Stock, one right and one -halfof one NorthView warrant. Each right entitles the holder thereof to receive one -tenth(1/10) of one share of common stock upon the consummation of an initial business combination and each warrant entitles the holder thereof to purchase one share of common stock for $11.50 per share, subject to adjustment. As of May13, 2025, the record date, the closing price of the NorthView Common Stock, the NorthView Warrants, and the NorthView Rights were $12.10, $0.11 and $0.16 per security, respectively. •Following the IPO, including the exercise of the over -allotmentoption and the sale of the private placement warrants, a total of $191,647,500 was deposited into a U.S. -basedtrust account with Continental Stock Transfer & Trust Company, acting as trustee. Except as described in the prospectus for the IPO, these proceeds will not be released until the earlier of the completion of an initial Business Combination and NorthView’s redemption of 100% of the outstanding public shares upon its failure to consummate a Business Combination within the completion window. •In connection with a special meeting of NorthView stockholders, held on March10, 2023, the NorthView stockholders elected to redeem 18,000,868 public shares of NorthView Common Stock related to the extension of NorthView’s business combination period monthly, for up to nine months, from March22, 2023, ultimately until as late as December22, 2023. Separately, the NorthView stockholders previously elected to redeem 140,663 public shares of NorthView Common Stock in connection with a shareholder meeting on December21, 2023, related to the extension of NorthView’s business combination period monthly, for up to